医師と一緒に読むページこのトピックは、検査や画像の解釈、神経・心臓・血液・肝臓・腎臓・肺の疾患、手術、薬剤、複雑な基礎疾患を含むことがあります。BioConst は説明に限定し、個人判断や対応の助言は行いません。
これは何か
Fatty liver disease means fat is present in the liver and is interpreted with metabolic and fibrosis context.[1,2]
感じられること
- NAFLD is also referred to as MASLD in NIDDK patient material.[1,2]
- Blood tests, imaging, and sometimes biopsy may enter diagnosis and staging context.[1,2]
なぜ起こるか
- Metabolic factors such as obesity, insulin resistance, diabetes, triglycerides, and metabolic syndrome can increase risk.[1,2]
- Other causes of liver fat and alcohol-associated liver disease need clinical separation.[1,2]
臨床対応の方向
- Clinical teams may use history, exam, labs, imaging, and specialist review depending on fatty liver context.[1,2]
- BioConst explains the map and does not diagnose, rank urgency, choose tests, or recommend treatment.[1,2]
よくある誤解
- Fat on imaging does not automatically identify inflammation.[1,2]
- Normal enzymes do not automatically exclude clinically important disease.[1,2]
- Fatty liver is not a supplement target or a one-number problem.[1,2]